SUBMIT YOUR INTEREST

Abstract Submission

DEADLINE: Friday, Dec. 4., 2026

In addition to our invited speakers, we're looking for dynamic presenters to speak at the conference with abstracts detailing extractables and leachables advancements, case studies, product developments and more!

If you would like to inspire discussion and development, we want to hear from you! Presenting is an ideal way to position you and your company as E&L thought leaders with a pulse on the industry.

For any questions or concerns with meeting the upcoming deadline, please feel free to contact Sandra Haines at shaines@smithers.com.

  • Evolving regulatory expectations – ICH Q3E, FDA guidance, USP, ISO, PQRI and global regulatory developments
  • ICH Q3E in practice – industry readiness, implementation strategies and potential impact on E&L programs
  • USP <665> implementation – practical experiences, challenges and lessons learned
  • Regulatory submissions and agency interactions – case studies, challenges, questions and successful approaches
  • Advances in analytical chemistry – LC-MS/HRMS, GC-MS, method development, identification and quantitation strategies
  • Non-targeted screening and unknown identification – workflows, data interpretation and orthogonal analytical approaches
  • Real-world E&L case studies – lessons learned, unexpected findings, investigations and problem solving
  • Extractables study design and laboratory variability – improving consistency, robustness and data quality
  • Toxicological and risk assessment strategies – practical approaches for pharmaceuticals, medical devices and combination products
  • Medical device chemical characterization – evolving regulatory expectations, analytical strategies and submission experience
  • Manufacturing systems and materials – single-use systems, production components, packaging and material selection
  • Emerging science and technology – predictive modelling, automation, AI/data tools and other innovations affecting E&L
  • Emerging contaminants and materials of concern – PFAS, nitrosamine precursors and other developing E&L challenges
  • New and emerging E&L topics – we also welcome abstracts addressing important areas not listed above.

Submit Your Paper